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Bad science and how to avoid it, a movement analysis perspective: 
Study design, Statistics and Publication Ethics 
Andy Kerr, Robin Prescott, Tim Theologis 
 
Introduction (Tim Theologis) 
Stepping down from the Editor-in-Chief post for Gait and Posture after 10 years gave me the 
opportunity to write a last editorial as an expression of gratitude to all of those who made 
these years a fantastic experience. I thought that a modest article offering general advice on 
how to avoid pitfalls when writing papers would be appropriate. I asked for the contribution 
of two excellent colleagues, who participated in an ESMAC seminar on the same subject in 
2013. I hope that the result is informative and helpful. I am very grateful to Dr Andy Kerr and 
to Professor Robin Prescott for their work on this article. 
I would like to take this opportunity to express my deep gratitude to all Readers, Reviewers 
and Authors of Gait and Posture for their contributions to the success of this journal. I am 
fully aware of the fact that Reviewers dedicate valuable time within a busy schedule in order 
to provide a service to Gait and Posture and maintain the good quality of published articles. I 
am also aware that Authors choose Gait and Posture among a large number of potential 
target journals and would like to thank them for their confidence in our journal.   
I am very grateful to the Editorial Board for the time and effort they dedicate in ensuring that 
quality is maintained and that the journal continues to reflect the interests and future 
directions of the Societies it represents. For the last 10 years I have relied heavily on the hard 
work, dedication and commitment of the Associate Editors¶WHDP(DFKRQHRIWKHPSURYLGHV 
leadership in a specific field of expertise. As a team, I believe we ensured that Gait and 
Posture continued to publish research reflecting the multi-disciplinary character of our 
journal and remained relevant to both clinicians and scientists. I could not have done it 
without them and I am very grateful for their support. Finally, I am grateful to our Publishers, 
Elsevier, for their support and their excellent work, which contributes greatly to the success 
of the journal. 
I leave the journal entirely confident that, under its new leadership, its future is bright. With 
the continuing support of Authors, Reviewers and the Societies, Gait and Posture can only go 
from strength to strength.  
Bad Science and Study Design (Andy Kerr) 
/HW¶V be positive, researchers and research groups, do not intend to conduct bad science, at 
least not at the outset. Nevertheless, we are all aware of alarming and risible examples of bad 
science. When this work passes through the peer review system to publication the effect not 
only damages progress in those areas but also erodes trust from the public who, after all, fund 
our work.  In our area of movement analysis we are not immune. Like most communities, bad 
science should only be encountered by our band of anonymous reviewers and journal editors, 
but the review process is not perfect, some questionable papers slip will, and do, slip through. 
Many factors contribute to bad science being given a full natural life, from conception to 
dissemination; ignorance, statistical naivety, money (both a lack and possibly too much) and 
technology (having the kit and no wit). At the ESMAC conference in Glasgow (2013) we 
organised a seminar aimed at shining a light on these factors, in the hope that we can all learn 
by them, much like the Raspberry awards in Hollywood try to do for the film making 
industry. 
As every conference presenter knows an audience needs a simple take home message.  To 
round off our seminar we generated a list of top tips from all the presenters which we 
presented to the audience with the ambition of reducing this list to a top 5 through debate and 
GLVFXVVLRQ:HEHJDQZLWKFRQWULEXWLRQV³Understand any assumptions in the methods 
you are using´;  ³Be clear in your presentation´; ³Don't try to hide 'bad news' about 
your research´; ³Have clear objectives and pre-specified hypotheses´; ³Put a lot of 
effort into designing your study´; ³Make a genuine a priori hypothesis for any research 
that you do´; ³Don't report too many results in the results section!´³ Write statements 
in your Discussion that make a tingle go up and down your spine and that you would be 
proud to read in 20 \HDUV¶WLPH´; ³have a clear question´; ³demonstrate the need to 
answer the question´; and 11) describe clearly the method 
The short period of lively discussion revised this list down to a top 5, ranked in order of 
popularity. 
1. Have a clear question. 
2.  Understand any assumptions you are using and describe the methods clearly. 
3.  Put a lot of effort into designing your study. 
4.  Don't try to hide 'bad news' about your research. 
5.  Demonstrate the need to answer the question. 
We consider this a valuable take home message. 
 
Using Statistics to come to the wrong conclusion (Robin J Prescott) 
One definition of statistical methods is those that are used to elucidate data that are affected 
by a multitude of causes. This aim of elucidation is often unappreciated and an alternative 
aim of maximising the nXPEHURIµVWDWLVWLFDOO\VLJQLILFDQW¶S-values often appears to be an 
REMHFWLYHRIVRPHDXWKRUV7KXVZHPLJKWVHH³SDWLHQWVZDONHGVLJQLILFDQWO\VORZHULQWKH
slow speed trials (mean 0.81 m/s, SD=0.11) than in the comfortable speed trials (1.03 m/s, 
SD=0.1W S´7KHUHVXOWVDUHYHU\FOHDUO\SUHVHQWHGEXWWKHUHLVQRVHQVLEOH
Null hypothesis to test. The hypothesis that speed is the same in slow speed trials and 
comfortable speed trials is untenable irrespective of the data. 
 
Are statistical errors common? There have been multiple surveys over the past 40 years to 
suggest that the published medical literature contains many errors, and that the wrong 
conclusions can be drawn. Errors in the manuscripts submitted to journals will be even more 
common and a recent survey of 100 papers submitted to Injury and subject to statistical 
review led to rejection or changes in 90. Some aspect of the analysis needed to be changed in 
47 and errors were found in 45. Suggestions for an improved presentation were made in 73. 
 
The problems that arise cover a wide spectrum and the following topics are only illustrative. 
Multiple testing can easily lead to errors in interpretation of results. In totally uninformative 
datasets, from its definition, 5% of significance tests can be expected to show statistical 
VLJQLILFDQFHDWWKHOHYHO7KXVZKHQPDQ\WHVWVDUHFRQGXFWHGVRPHRIWKHµSRVLWLYH¶
findings are likely to be false positives. In a recently published paper, one of the tables 
showed tests applied WRYDULDEOHV(OHYHQZHUHVKRZQDVµ16¶EDGSUDFWLFHLQLWVHOIZKLOH
RQHJDYHS 7KHFRUUHVSRQGLQJWH[WKLJKOLJKWHGWKLVµVLJQLILFDQW¶ILQGLQJZKLFKLQ
reality, is highly likely to be due to chance. Interpretation of findings after many tests must 
always be cautious, which is why a single primary outcome measure is encouraged in clinical 
trials. 
 
Misleading conclusions can also be drawn after the application of data driven hypotheses. 
There is a logical fallacy in using data to derive a hypothesis and then using the same data to 
test the hypothesis. This type of problem occurs in a range of forms. A simple one is finding a 
predictive cut-point in a variable such as age or some clinical variable from the data and then 
showing its effectiveness on the same data. This extends into classification trees and clinical 
decision rules. These methods can be very valuable but it is essential that are evaluated on an 
independent dataset or the evaluation will be severely biased. 
 
It seems that many of the standard statistical tests are applied without an understanding of 
their assumptions. An assumption that is often overlooked is that the observations should be 
independent of each other. A common reason for this to be violated is when we have bilateral 
data. Ignoring the pairing and treating every observation separately is invalid and leads to 
overly optimistic p-values and confidence intervals. Using the average of left and right is 
valid, as is a repeated measures analysis of variance, but will be inefficient if there are any 
missing observations. Mixed or multi-level models allow an optimal analysis of such data. 
 
Sub-group analysis is another minefield for the unwary. As well as examining overall 
differences between groups (often treatment groups), it is tempting to repeat the analysis for 
sub-groups, say for men and women. The fallacy is to test each group separately when the 
question that should be posed first is whether there is evidence that men and women differ 
from each other in the effect of treatment. In statistical terminology this is testing for a 
treatment by gender interaction. Only if this is significant or there is a priori information to 
suggest such an interaction, should sub-groups be analysed separately. 
 
Last, but certainly not least, it is important to appreciate the reasons why tests may be 
statistically significant or non-significant and interpret our findings accordingly. We may 
achieve p<0.05, because there is good evidence of a genuine departure from the Null 
hypothesis: e.g. there may be a genuine treatment difference. On the other hand it could be 
due to chance, there might be bias in our comparisons, or we might have applied an 
inappropriate test. Conversely, a non-significant difference might occur because the Null 
hypothesis is true or it might be due to chance, inappropriate analysis or, very commonly, 
because the study is too small to have a good chance of detecting an important difference.  
 
Statistical methods should be applied with thought given to their initial use and to the 
interpretation of the findings. Many statisticians would argue that statistical thought has most 
benefit at the stage of designing a study, so that important differences or associations have a 
high probability of being shown as statistically significant. Statistics should never be thought 
of as black box technique to add respectability to a publication. The priority should be to 
conduct a well-designed study and present the results as fully and clearly as space permits, 
using statistical methods to enhance understanding.  
 
Publication Ethics (Tim Theologis) 
Publication of scientific research is governed by legal and ethical rules. The aim of those 
rules is to ascertain that the published material is the genuine product of bona fide research 
based on ethical standards and selected for publication through a fair peer review process. 
The rules that govern publication ethics are complex as the boundaries of ethical acceptability 
are often unclear. This section touches upon some of the most commonly encountered issues 
related to publication ethics but does not comprehensively cover this enormous and 
complicated subject. Additional information and help for authors, reviewers and editors can 
be found on the website of the Committee of Publication Ethics (COPE) at 
http://publicationethics.org/ . 
Publication bias is a bias with regard to what is likely to be published, among what is 
available to be published. Publication bias occurs when the publication of research results 
depends on their nature and direction rather than the quality and relevance of the research. A 
FRPPRQIRUPRISXEOLFDWLRQELDVFRQFHUQVSXEOLFDWLRQVSUHVHQWLQJ³QHJDWLYH´UHVXOWVZKLFK
confirm the null hypothesis or, in other words, they do not prove the hypothesis on which the 
research question is based. It is true that journals often show a preference in publishing 
papers with positive findings. Researchers may also decide not to submit papers which 
confirm the null hypothesis bHFDXVHWKH\SHUFHLYHDODFNRILQWHUHVWRQWKHUHDGHUV¶EHKDOIRU
because they have lost interest and motivation. Therefore, negative research findings often 
remain unpublished. This leads to significant bias when systematic reviews and meta-
analyses are conducted. The positive findings of multiple publications are not counter-
balanced by the negative findings of unpublished work. 
Adequately powered studies with appropriate assessment of the probability for a false 
positive result can overcome this difficulty as they usually convince peer reviewers of the 
genuine result. Registration of research study protocols and data collection with the relevant 
clinical or academic authority would also prevent studies leading to negative results from 
remaining unfinished or un-reported. 
$QRWKHUIRUPRISXEOLFDWLRQELDVKDVEHHQWHUPHG³HARKing´RU+\SRWKHVLVLQJ$IWHUWKH
Results are Known [1]. Good quality research should include an a priori hypothesis or 
research question. Collecting data and undertaking multiple comparisons (as it is often the 
case with gait analysis data) without a pre-defined hypothesis can lead to false positive results 
and an often complicated and improbable interpretation of those in the discussion. 
Redundant publication or duplication is the publication of work based on previously 
published datasets and findings by the same team of researchers. In cases of major 
redundancy, the content of the manuscript is similar to the already published material. 
Attempts to hide the rHGXQGDQF\E\FKDQJLQJWKHWLWOHRUWKHDXWKRUV¶RUGHUDQGE\IDLOLQJWR
refer to the previous publication usually indicate intentional duplication. This constitutes a 
serious misconduct which contradicts the authorship statement required by most publishers. If 
the attempt to publish redundant material is substantiated, the editors are obliged to report the 
DWWHPSWWRWKHDXWKRUV¶LQVWLWXWLRQDQGWRUHMHFWRUUHWUDFWWKHPDQXVFULSW0RUHRIWHQWKH
boundaries of redundant publication are less clear. Publishing multiple papers from 
subsections of the same research project, based on a single dataset obtained from the same 
experiment or same sample, is common practice. It is usually left to the editors to decide what 
constitutes duplication. If different papers address a different audience and raise different 
points in the discussion, present an extended follow-up or are written in a different language, 
they are usually considered acceptable. The editors, however, have to be satisfied that the 
manuscript under consideration constitutes original work as a stand-alone document. 
Plagiarism is the unattributed use of large portions of text or data presented as if they were 
SURGXFHGE\WKHSODJLDULVW7KLVDOVRUHSUHVHQWVVHULRXVPLVFRQGXFWFRQWUDGLFWLQJWKHDXWKRUV¶
statement submitted to the publishers. If the editors are convinced of the plagiarism they are 
REOLJHGWRUHSRUWLWWRWKHDXWKRUV¶LQVWLWXWLRQDQGWRUHMHFWRUUHWUDFWWKHPDQXVFULSW7KHVDPH
principles apply to Data Fabrication. An increasing number of scientific journals request 
submission of the raw data by the authors in order to prevent this misconduct. 
Authorship disputes are unfortunately common in scientific publication. Defining clear 
roles and ownerships at the start of a research project should prevent such disputes. Most 
journals require written confirmation of all authors in order to change the authorship of a 
paper. They also require written explanation of the reasons for the change. Editors and 
reviewers should always be aware of Gift authorship (the inclusion of an author who did not 
contribute to the work) or Ghost authorship (the exclusion of an individual who contributed 
significantly to the project). The boundaries of what is ethical in this practice are often ill-
defined and reaching a judgement in some cases of authorship dispute can be challenging. 
The World Association of Medical Editors (WAME, www.wame.org) has defined as 
Conflict of Interest &,WKH³GLYHUJHQFHEHWZHHQDQLQGLYLGXDO¶VSULYDWH interests and his or 
her responsibilities to scientific and publishing activities such that a reasonable observer 
PLJKWZRQGHULIWKHLQGLYLGXDO¶VEHKDYLRURUMXGJPHQWZDVPRWLYDWHGE\
considerations of his or her competing LQWHUHVWV´7KHPDWWHURI&,FRQFHUQVDXWKRUV
reviewers and editors and is an important ethical issue to consider in scientific publication. 
Financial ties in the form of funds, patents, stocks, gifts or services relating to a specific 
research project have to be declared and considered. Financial CI should also be considered 
when there are ties to the industry or commercial bodies and include payment for research, 
ownership of stock and stock options, honoraria for advice, public speaking or consultation, 
service on advisory boards, service on scientific/medical education companies, 
receipt of patents or patents pending or holding a post funded by the industry. However, CI is 
not always financial. Academic CI may exist when individuals have strong beliefs in a 
particular research domain or belong to a competing team or institution. Personal CI may 
exist when family and close friends, competitors or current/previous colleagues are involved 
in the process of peer review and publication. Political or religious CI should also be 
considered. Most scientific journals expect authors to declare CI on submission of an article. 
Whether or not the review and publication of an article can proceed despite a CI or not is left 
to the discretion of the editors. Reviewers, editors and the readers should exercise their 
judgement on the credibility of scientific articles taking into account the declared CI. Finally, 
editors are expected to consider CI, not only when assessing routinely submitted work but ±
particularly- when dealing with their own research or work submitted from their own 
institution. 
Good quality research and the scientific publication process should be based on solid ethical 
principles. Researchers, reviewers and editors should ensure that ethical questions and 
dilemmas are fully addressed before an article is submitted and published. This will protect 
the reader from misinformation and potential harm.  As stated above, additional information 
and help for authors, reviewers and editors can be found on the website of the Committee of 
Publication Ethics (COPE) at http://publicationethics.org/ . Two interesting as well as 
entertaining articles referenced below provide further guidance on conducting scientific 
research and on writing an original article [2,3]. 
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